75
Views
12
CrossRef citations to date
0
Altmetric
Brief Report

The safety of a novel sublingual rush induction phase for latex desensitization

, , , , , & show all
Pages 1855-1859 | Accepted 04 Jun 2010, Published online: 03 Jun 2010

References

  • Zak HN, Kaste LM, Schwarzenberger K, et al. Health-care workers and latex allergy. Arch Environ Health 2000;55:336-46
  • Nettis E, Assennato G, Ferrannini A, et al. Type I allergy to natural rubber latex and type IV allergy to rubber chemicals in health care workers with glove related skin symptoms. Clin Exp Allergy 2002;32:441-7
  • Ruëff F, Kienitz A, Schöpf P, et al. Frequency of natural rubber latex allergy in adults is increased after multiple operative procedures. Allergy 2001;56:889-94
  • Bousquet J, Flahault A, Vandenplas O, et al. Natural rubber latex allergy among health care workers: a systematic review of the evidence. J Allergy Clin Immunol 2006;118:447-54
  • Nettis E, Colanardi MC, Soccio AL, et al. Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study. Br J Dermatol 2007;156:674-81
  • Patriarca G, Nucera E, Pollastrini E, et al. Sublingual desensitization: a new approach to latex allergy problem. Anesth Analg 2002;95:956-60
  • Nettis E, Colanardi MC, Ferrannini A. Type I latex allergy in health care workers with latex-induced contact urticaria syndrome: a follow-up study. Allergy 2004;59:718-23
  • Malling HJ, Weeke B. EAACI immunotherapy position paper. Allergy 1993;48:9-35
  • Stelmach I, Kaczmarek-Woźniak J, Olszowiec-Chlebna M, Jerzynska J. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Clin Exp Allergy 2009;39:401-8
  • Rossi RE, Monasterolo G. A pilot study of feasibility of ultra-rush (20–25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma. Int J Immunopathol Pharmacol 2005;18:277-8
  • Nucera E, Schiavino D, Sabato V, et al. Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase. Curr Med Res Opin 2008;24:1147-54
  • Frati F, Incorvaia C, Marcucci F, et al. Dose dependence of efficacy but not of safety in sublingual immunotherapy. Monaldi Arch Chest Dis 2006;65:38-40
  • Gidaro GB, Marcucci F, Sensi L, et al. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy 2005;35:565-71
  • Sastre J, Fernandez-Nieto M, Rico P, et al. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study. J Allergy Clin Immunol 2003;111:985-94

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.